Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN07033239Phase 2Completed
Phase 2, randomised trial of benzydamine in stomatitis, sponsored by Imam Hossein Hospital. Primary endpoint: Reduction of mucositis. Started Jun 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN07033239.